| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $109.6M | +2.5% |
| Cost of Revenue | $14.2M | +10.9% |
| Gross Profit | $95.4M | +1.3% |
| R&D Expense | $74.8M | +4.5% |
| SG&A Expense | $18.1M | +7.2% |
| Operating Income | -$11.3M | -50.4% |
| Pre-tax Income | -$4.7M | -70.2% |
| Income Tax | $5.9M | -1.4% |
| Net Income | -$10.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.6M | +119.4% |
| Accounts Receivable | $49.4M | +32.6% |
| Current Assets | $284.8M | +31.7% |
| Total Assets | $388.3M | +25.7% |
| Current Liabilities | $28.7M | -6.0% |
| Stockholders' Equity | $336.5M | +26.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.4M | -196.7% |
| Capital Expenditures | $2.9M | -1.2% |
| Investing Cash Flow | -$34.0M | -1289.9% |
| Financing Cash Flow | $59.3M | +1164.7% |
| Free Cash Flow | -$6.3M | -1316.5% |
| -21.1% |
| EPS (Basic) | -$0.44 | -18.9% |
| EPS (Diluted) | -$0.44 | -18.9% |